Sep 27: 2 Strong Themes — Travel, Vaccines, Diagnostics & Epidemic Control
2 strong themes — 2 recurred. Top: Travel +4.5%.
Average change by strong theme
Theme leaders · recent trend
| Theme | Leader | Change | Trend |
|---|---|---|---|
| Travel | SM Culture & Contents | +7.22% | |
| Vaccines, Diagnostics & Epidemic Control | EyeGene | +6.40% |
On 2017-09-27, two themes came back strong after long breaks. Travel returned after 133 days with an average change of 4.53%, and all 3 of its stocks closed higher.
SM Culture & Contents led Travel, rising 7.22% to close at 2895. A Korean news report linked the move to expected growth in ad billings. RedcapTour rose 3.23% and Sejoong gained 3.15%.
Vaccines, Diagnostics & Epidemic Control returned after 114 days with an average change of 4.07%. EyeGene led with a 6.4% gain. A Korean news report noted foot-and-mouth vaccine stocks moving up.
Today’s Strong Themes at a Glance
| # | Theme | Status | Avg. change | Up/Total | Leader |
|---|---|---|---|---|---|
| 1 | Travel | recurred after 133 days | +4.5% | 3/3 | SM Culture & Contents |
| 2 | Vaccines, Diagnostics & Epidemic Control | recurred after 114 days | +4.1% | 3/3 | EyeGene |
Theme by Theme
1. Travel (recurred after 133 days)
- Episode: started 2017-09-27, day 1
| Stock | Change | Close | Leader |
|---|---|---|---|
SM Culture & Contents 048550 | +7.2% | 2,895 | ★ |
RedcapTour 038390 | +3.2% | 8,000 | |
Sejoong 039310 | +3.1% | 2,950 |
Related news
- [특징주]SM C&C, 광고 취급고 성장 기대에 강세 — 이데일리 (Korean)
- [ET투자뉴스]SM C&C_外人 대량매수 이후 주가도 탄력 받아 현재 +5.56% — 전자신문 (Korean)
2. Vaccines, Diagnostics & Epidemic Control (recurred after 114 days)
- Episode: started 2017-09-27, day 1
| Stock | Change | Close | Leader |
|---|---|---|---|
EyeGene 185490 | +6.4% | 11,747 | ★ |
Eagle Veterinary Technology 044960 | +3.5% | 5,380 | |
Choong Ang Vaccine Laboratory 072020 | +2.3% | 14,173 |
Related news
- [구제역 백신 테마]이-글 벳(+3.85%) 중심으로 상승중 — 헤럴드경제 (Korean)
Closing Thoughts
Both themes are on a streak of 1, and each episode lasted a single day. The next sessions will show whether either run continues.
For Travel, it matters whether the gains spread beyond SM Culture & Contents, since RedcapTour traded only 3284 shares. In the vaccine theme, the question is whether EyeGene’s 6.4% move gets any follow-through.